Camptothecin (botanical extract)

Chinese botanical extraction and pharmaceutical API company headquartered in Guangxi province — the heart of Camptotheca acuminata cultivation territory. Haoshu is among the largest producers of camptothecin and its hydroxylated derivative 10-hydroxycamptothecin (10-OHCPT) extracted from Camptotheca acuminata bark, wood, and leaves, and is a significant irinotecan API manufacturer supplying both domestic Chinese generic pharmaceutical companies and international API buyers. Guangxi's subtropical climate and rich red-clay soils support large Camptotheca acuminata plantations; Haoshu's vertical integration from plantation to API distinguishes it from pure chemical API manufacturers. The company also produces other phytochemical APIs from Chinese medicinal plant sources.

Chinese pharmaceutical API manufacturer based in Shanxi province; significant producer of camptothecin API and related semi-synthetic intermediates. Shanxi Fenge processes camptothecin extracted from Camptotheca acuminata plant material sourced from cultivation regions (principally Guangxi, Fujian, and Jiangsu) and converts it to pharmaceutical-grade camptothecin powder used as a starting material for irinotecan and topotecan semi-synthesis. The company holds Chinese GMP certification and supplies API to Chinese generic drug manufacturers and international pharmaceutical buyers.

Shanghai-based botanical extract manufacturer specializing in phytochemical APIs including camptothecin and 10-hydroxycamptothecin extracted from Camptotheca acuminata. Shanghai Polyene supplies standardized camptothecin extracts to pharmaceutical companies globally for use as semi-synthetic precursors to irinotecan and topotecan. The company's Shanghai operations give it proximity to export logistics and international pharmaceutical purchasers in a way that inland Guangxi or Shanxi producers lack.

Indian multinational pharmaceutical company (NSE: DRREDDY; HQ Hyderabad) with significant irinotecan API and finished dose manufacturing. Dr. Reddy's manufactures irinotecan hydrochloride injection for the U.S. and European generic markets — one of the leading generic irinotecan suppliers approved by FDA and EMA. The company converts camptothecin (procured primarily from Chinese botanical extraction sources) into irinotecan API via semi-synthesis at its Hyderabad API facilities. Dr. Reddy's broader oncology generics franchise includes paclitaxel, docetaxel, and topotecan, making it one of the few Indian companies with a full camptothecin-class API portfolio. Supply of irinotecan to the U.S. critical care oncology market is a significant part of the company's FDA-regulated generic pharmaceutical business.

Italian botanical extract specialist headquartered in Milan; founded 1921 as a subsidiary of Recordati pharmaceutical group. Indena is the world's leading non-Chinese manufacturer of plant-derived pharmaceutical APIs including camptothecin-class compounds, paclitaxel, and other oncology botanicals. Indena sources Camptotheca acuminata plant material from China (and limited cultivation trials in Europe) and processes it at its Italian facilities under EMA GMP certification, supplying camptothecin and camptothecin derivatives to European and U.S. pharmaceutical manufacturers. Indena's non-China GMP-certified supply is particularly valuable to Western pharmaceutical companies seeking to diversify supply away from Chinese botanical sources for critical oncology APIs.